As inhibition of COX-2 and aromatase were reported to be beneficial for reducing endometriosis-related pain [113] and the reduction of its growth [61], the confirmed decrease in COX-2 and aromatase upon resveratrol treatment and reduction of pain in endometriosis patients with oral contraceptives is promising. This evidence concerns the gene CYP19A1 and endometriosis.